Aldehyde Dehydrogenase 1 Is a Tumor Stem Cell-Associated Marker in Lung Cancer
By F. Jiang, Qi Qiu, Abha Khanna, N. Todd, J. Deepak, L. Xing, Huijun Wang, Zhenqiu Liu, Yun Su, S. Stass and 1 more. Molecular Cancer Research, 2009
811 citations recorded by the source corpus.
Subfields: Cancer Research, Molecular Biology, Oncology
View Paper: https://www.semanticscholar.org/paper/511342a086236f66cae8d8fe3d7362e0d4b4c4dd
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Molecular Biology
Citations in the corpus
- Cancer Stem Cells (CSCs) in Drug Resistance and their Therapeutic Implications in Cancer Treatment (2018, background): “ALDH activity is a potential selective marker for cancer stem cells in many different types of cancer, such as breast cancer [53], bladder cancer [81], head and neck squamous cell carcinoma [82], lung cancer [83], and embryonal rhabdomyosarcoma [84].”
- Cancer Stem Cells—Origins and Biomarkers: Perspectives for Targeted Personalized Therapies (2020, neutral): “(39, 68, 69, 130)* (131) (132–134) (62, 128, 135)”